home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Charles River Laboratories International, Inc. Common Stock (NY:CRL)

172.50 +12.78 (+8.00%)

Official Closing Price Updated: 7:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Charles River Laboratories International, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023

November 09, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Labs Q3 Revenue Jumps 4% Despite Softer Client Spending, Narrows Outlook ↗

November 08, 2023

Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the

Via Benzinga

Charles River Laboratories Announces Third-Quarter 2023 Results

November 08, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

8 Analysts Have This to Say About Charles River ↗

October 24, 2023

Via Benzinga

What 5 Analyst Ratings Have To Say About Charles River ↗

September 13, 2023

Via Benzinga

Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business

October 19, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call

October 16, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research

October 16, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals

October 11, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar ↗

October 05, 2023

S&P 500 stocks are sliding amid a worrying interest rate environment. However, these three can buck the current downtrend.

Via InvestorPlace

Topics Stocks

Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing

September 26, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster

September 25, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories International, Inc. (NYSE: CRL) Long Term Investor Alert: Investigation of Potential Wrongdoing ↗

September 22, 2023

San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Charles River Laboratories International, Inc are under investigation concerning potential breaches of fiduciary duties.

Via SBWire

Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

September 21, 2023

Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.

Via Benzinga

Charles River Laboratories to Host Virtual Investor Day

September 20, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica

September 14, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

September 11, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead. ↗

September 06, 2023

VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead.

Via InvestorPlace

Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods

September 06, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories ↗

August 25, 2023

Wall Street Journal

Via Benzinga

Topics Bankruptcy

Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection ↗

August 25, 2023

Charles River Laboratories International Inc (NYSE: CRL) has joined hands with four significant entities in a pioneering move to amplify protections for the horseshoe crabs and the red knots bird...

Via Benzinga

Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon

August 24, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

August 22, 2023

From Bragar Eagel & Squire, P.C.

Via Business Wire

B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know ↗

August 10, 2023

Via Benzinga

US Stocks Edge Lower; Charles River Earnings Top Estimates ↗

August 09, 2023

U.S. stocks were mostly lower this morning, with the Nasdaq Composite falling more than 50 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.03% to 35,303.64 while the...

Via Benzinga

Charles River Laboratories Announces Second-Quarter 2023 Results

August 09, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

Lyft, Disney And 3 Stocks To Watch Heading Into Wednesday ↗

August 09, 2023

With U.S. stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Investor Sentiment Declines After Moody's Downgrades Credit Ratings Of Banks ↗

August 09, 2023

The CNN Money Fear and Greed index showed a decline in overall sentiment among U.S. investors on Tuesday. U.S. stocks closed lower on Tuesday after Moody's downgraded the credit ratings of several US...

Via Benzinga

Buy Alert: 3 Healthcare Stocks Nearing Super Attractive Entry Points ↗

August 02, 2023

Explore the resilience of healthcare stocks that are demonstrating signs of recovery, with robust long-term growth potential ahead.

Via InvestorPlace

Charles River Laboratories Expands Access to AAALAC-Accredited, Turnkey Research Space in Key Markets

August 01, 2023

From Charles River Laboratories International, Inc.

Via Business Wire

< Previous 1 2

...

8 9 10 11 12 13 14 15 16

...

20 21 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com